Higher cancer antigen 125 level is associated with the presence of permanent atrial fibrillation in systolic heart failure patients
ACTA CARDIOLOGICA, cilt.71, sa.1, ss.61-66, 2016 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 71 Sayı: 1
- Basım Tarihi: 2016
- Doi Numarası: 10.1080/ac.71.1.3132099
- Dergi Adı: ACTA CARDIOLOGICA
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.61-66
- Anahtar Kelimeler: Cancer antigen-125, CA-125, systolic heart failure, atrial fibrillation, C-REACTIVE PROTEIN, CARBOHYDRATE ANTIGEN-125, PROGNOSTIC-SIGNIFICANCE, OVARIAN-CANCER, CA-125 LEVELS, SERUM, INFLAMMATION, RECOMMENDATIONS, ELEVATION, BENIGN
- Çanakkale Onsekiz Mart Üniversitesi Adresli: Hayır
Özet
Introduction Atrial fibrillation (AF) is a common arrhythmia in heart failure (HF). Recent studies have shown that serum cancer antigen-125 (CA-125) levels are elevated in HF, and high levels of CA-125 in HF patients with sinus rhythm have been shown to be associated with the development of new onset AF. However, the relation between CA-125 levels and the presence of AF in HF is unknown. In this study we investigated whether plasma CA-125 levels in patients with systolic HF could predict the presence of AF.